نتایج جستجو برای: melphalan

تعداد نتایج: 4419  

Journal: :The Journal of organic chemistry 2012
Abhigna Polavarapu Jacob A Stillabower Skyler G W Stubblefield William M Taylor Mu-Hyun Baik

The thermodynamics and kinetics for the monofunctional binding of nitrogen mustard class of anticancer drugs to purine bases of DNA were studied computationally using guanine and adenine as model substrates. Mechlorethamine and melphalan are used as model systems in order to better understand the difference in antitumor activity of aliphatic and aromatic mustards, respectively. In good agreemen...

2013
Martin Bøgsted Anders E. Bilgrau Christopher P. Wardell Uta Bertsch Alexander Schmitz Julie S. Bødker Malene K. Kjeldsen Hartmut Goldschmidt Gareth J. Morgan Karen Dybkaer Hans E. Johnsen

In a conceptual study of drug resistance we have used a preclinical model of malignant B-cell lines by combining drug induced growth inhibition and gene expression profiling. In the current report a melphalan resistance profile of 19 genes were weighted by microarray data from the MRC Myeloma IX trial and time to progression following high dose melphalan, to generate an individual melphalan res...

Journal: :Cancer research 1988
C N Coleman R W Carlson R A Artim W I Sampson H J Lawrence P Wong J Halsey M Kohler M Gribble B I Sikic

One hundred patients with non-small cell lung cancer were entered by members of the Northern California Oncology Group into a randomized Phase II trial of i.v. melphalan versus i.v. melphalan with concomitant oral misonidazole. The patients had not received prior chemotherapy. Eighty-five patients were evaluable for assessment of response and 89 were evaluable for toxicity analysis. The melphal...

Journal: :The New England journal of medicine 2008
Jesús F San Miguel Rudolf Schlag Nuriet K Khuageva Meletios A Dimopoulos Ofer Shpilberg Martin Kropff Ivan Spicka Maria T Petrucci Antonio Palumbo Olga S Samoilova Anna Dmoszynska Kudrat M Abdulkadyrov Rik Schots Bin Jiang Maria-Victoria Mateos Kenneth C Anderson Dixie L Esseltine Kevin Liu Andrew Cakana Helgi van de Velde Paul G Richardson

BACKGROUND The standard treatment for patients with multiple myeloma who are not candidates for high-dose therapy is melphalan and prednisone. This phase 3 study compared the use of melphalan and prednisone with or without bortezomib in previously untreated patients with multiple myeloma who were ineligible for high-dose therapy. METHODS We randomly assigned 682 patients to receive nine 6-wee...

2006
PHILIPPE MOUGENOT MICHEL FABBRO FRANÇOISE BRESSOLLE DAMIEN POUESSEL STEPHANE CULINE FREDERIC PINGUET

The current study was performed to evaluate the efficacy and toxicity of a chemotherapy treatment using melphalan administered over a 24-h period with individual adapted dosing in advanced ovarian cancer. Melphalan was infused intravenously with an automatic infusion pump over a 24-h period. The schedule was repeated every 28 days for a maximum of 6 cycles. The initial administered dose was 25 ...

Journal: :Haematologica 2009
Saulius Girnius David C Seldin Martha Skinner Kathleen T Finn Karen Quillen Gheorghe Doros Vaishali Sanchorawala

High-dose melphalan chemotherapy and autologous peripheral blood stem cell transplantation has been shown to result in durable hematologic response and prolonged overall survival in systemic AL amyloidosis. In this retrospective study, we evaluated clinical and hematologic responses in 69 patients with predominant liver involvement who were treated with high-dose intravenous melphalan and autol...

2016
Xunda Ji Peiyan Hua Jing Li Jiakai Li Junyang Zhao Peiquan Zhao

Purpose. To evaluate the efficacy of intravitreal melphalan for vitreous seeds from retinoblastoma in Chinese patients. Methods. This is a retrospective review of 17 consecutive Chinese patients (19 eyes) with viable vitreous seeds from retinoblastoma. The patients received multiple intravitreal injections of 20 ug melphalan. Results. The International Classification of Retinoblastoma groups we...

Journal: :Cancer research 1988
R L Page D W Macy D E Thrall M W Dewhirst S L Allen G L Heidner D A Sim M L McGee E L Gillette

A multiinstitutional Phase I study using i.v. melphalan was conducted in dogs with spontaneously occurring neoplasia. Melphalan was administered at 7.5, 10, 11.25, 12.5, and 20 mg/m2 of body surface area. Disproportionately greater toxicity was observed in small dogs. Seven of the eight dogs (88%) weighing less than 14 kg experienced severe myelosuppression (neutropenia, less than 1500/mm3; and...

Journal: :Mutagenesis 2007
Patricia A Escobar Martyn T Smith Ananth Vasishta Alan E Hubbard Luoping Zhang

Acute myeloid leukaemia (AML) is associated with exposure to benzene and treatment with chemotherapeutic agents. It is thought to arise from damage to specific regions of DNA, resulting in chromosome rearrangements or loss. For instance, a deletion on the long arm of chromosome 5 [e.g. del(5q31)] is common in AML patients previously treated with alkylating agents, such as melphalan, or exposed ...

Journal: :The British journal of surgery 1996
E R Manusama P T Nooijen J Stavast N M Durante R L Marquet A M Eggermont

The efficacy of isolated limb perfusion (ILP) for 'intransit' metastases from malignant melanoma and irresectable soft tissue sarcoma has been improved considerably by the addition of tumour necrosis factor (TNF) alpha. A rat sarcoma tumour model was, therefore, developed to evaluate the effects of TNF-alpha, melphalan and the combination of these drugs in the treatment of sarcoma. In BN rats b...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید